Pfizer

American multinational pharmaceutical and biotechnology corporation

Follow Pfizer on Notably News to receive short updates to your email — rarely!

2025 Pfizer earned a 100% score from the Human Rights Campaign on the Corporate Equality Index for LGBTQ workplace equality, highlighting the company's commitment to creating an inclusive work environment.
February 2025 Donald Trump announced he was considering four exemptions to reciprocal tariffs, specifically mentioning the pharmaceutical industry as a potential exemption.
February 2025 Pfizer's CEO Albert Bourla emphasized the company's ability to mitigate potential tariffs by shifting manufacturing to its 13 U.S. facilities.
2024 Pfizer ranked highly in the Hispanic Association on Corporate Responsibility Corporate Inclusion Index and was named a 'Best Place to Work for Disability Inclusion' in the Disability Equality Index. The company also received awards including Top Diverse Employer, Top Hispanic Employer, and Top Disability-Friendly Company by DiversityComm, Inc.
2024 Pfizer ranked highly in the Hispanic Association on Corporate Responsibility Corporate Inclusion Index, demonstrating strong corporate diversity and inclusion efforts.
September 30 2024 Pfizer announced its intentions to sell 540 million Haleon shares, worth approximately £2.1 billion ($2.8 billion).
July 2024 Pfizer and Flagship Pioneering announced an 'Innovation Supply Chain' partnership to co-develop 10 drug candidates, with each party committing $50 million upfront. The partnership leverages Flagship's startup ecosystem, with potential success milestones and royalties up to $700 million per commercialized drug.
2023 Pfizer was named one of 'America's Greatest Workplaces' by Newsweek and received Clinical Trials Arena Excellence Awards. The company was also included in the top 10 of Fortune's 'World's Most Admired Companies'.
December 2023 Pfizer acquired Seagen, a pioneer of antibody–drug conjugates for cancer treatment, for $43 billion.
April 2023 Pfizer moved its world headquarters from 42nd Street in Midtown Manhattan to the Spiral at Hudson Yards.
2022 Forbes listed Pfizer as a Top Employer for Diversity and Best Employer for Women.
October 2022 Pfizer acquired Biohaven Pharma and its calcitonin gene-related peptide programs for $11.6 billion, and also acquired Global Blood Therapeutics for $5.4 billion to boost its rare disease business.
June 2022 Pfizer acquired ReViral Ltd for up to $525 million, gaining access to experimental drugs for respiratory syncytial virus infections.
March 2022 Pfizer acquired Arena Pharmaceuticals for $6.7 billion in cash.
2021 Pfizer was recognized as a 'Best Place to Work' by Glassdoor and named a Top Employer by Science for its practices during the COVID-19 pandemic.
August 2021 Pfizer announced the acquisition of Trillium Therapeutics Inc and its immuno-oncology portfolio for $2.3 billion.
April 2021 Pfizer acquired Amplyx Pharmaceuticals and its anti-fungal compound fosmanogepix (APX001).
January 5 2021 Pfizer introduced a new corporate logo.
November 2020 Pfizer merged its off-patent branded and generic drug business, Upjohn, with Mylan to form Viatris, with Pfizer shareholders owning 57% of the new company.
October 2020 Pfizer acquired Arixa Pharmaceuticals.
September 2020 Pfizer acquired a 9.9% stake in CStone Pharmaceuticals for $200 million, helping to commercialise its anti-PD-L1 monoclonal antibody, CS1001.

This contents of the box above is based on material from the Wikipedia article Pfizer, which is released under the Creative Commons Attribution-ShareAlike 4.0 International License.

See Also